<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Respiratory muscle training and resting in COPD</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Respiratory muscle training and resting in COPD</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Respiratory muscle training and resting in COPD</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Bartolome R Celli, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Umur Hatipoglu, MD, MBA</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Paul Dieffenbach, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jun 15, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The respiratory muscles constitute a vital component of the respiratory pump. Their contraction during part of the breathing cycle changes the anatomic configuration of the thorax and displaces its components, so that air moves into and out of the gas exchanging portion of the lungs [<a href="#rid1">1-3</a>]. The importance of the respiratory musculature in chronic obstructive pulmonary disease (COPD) is underscored by diaphragmatic structural changes which render patients more resistant to fatigue, including an increased quantity of slow twitch fibers and slow isomers of myosin light chains, tropomyosin, and troponins [<a href="#rid4">4,5</a>].</p><p>The effect of training and resting the respiratory muscles in patients with COPD will be presented here. An overview of the management of stable COPD, tests of respiratory muscle strength, and the roles of pulmonary rehabilitation and nocturnal ventilatory support are discussed separately. (See  <a class="medical medical_review" href="/d/html/120326.html" rel="external">"Stable COPD: Overview of management"</a> and  <a class="medical medical_review" href="/d/html/1463.html" rel="external">"Pulmonary rehabilitation"</a> and  <a class="medical medical_review" href="/d/html/1453.html" rel="external">"Nocturnal ventilatory support in COPD"</a> and  <a class="medical medical_review" href="/d/html/6965.html" rel="external">"Tests of respiratory muscle strength"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">STRENGTH AND ENDURANCE TRAINING</span><span class="headingEndMark"> — </span>A number of studies have demonstrated that respiratory muscle strength and endurance can be increased with specific training, similar to skeletal muscle training [<a href="#rid6">6-10</a>]. A sufficient stimulus, such as greater than 30 percent of maximal force, is needed for training to occur.</p><p>Since reduced inspiratory muscle strength is evident in patients with COPD, considerable efforts have been made to define the role of respiratory muscle training in this setting. Theoretically, an increase in inspiratory muscle strength (and perhaps endurance) could result in improved respiratory muscle function. However, this may only be relevant when patients must handle inspiratory loads that are greater than baseline, such as during an acute exacerbation or exercise.</p><p>Inspiratory muscle training (IMT) improved the six-minute walk distance and reduced dyspnea in a study that compared expiratory, inspiratory, and combined training [<a href="#rid11">11</a>]. Systematic reviews and meta-analyses that included data from 55 randomized controlled trials (RCTs) have assessed the impact of IMT alone as well as IMT in addition to pulmonary rehabilitation (PR). IMT alone compared with no IMT or use of a sham device improves inspiratory muscle strength, endurance time, 6- or 12-minute walk distance, quality of life, and some measures of dyspnea, but much of the evidence is of poor quality and at risk for bias [<a href="#rid7">7,12</a>]. When added to PR (22 trials with 1446 participants), IMT did not meaningfully improve dyspnea scores, six-minute walk distance, or St. George's respiratory questionnaire score compared with PR alone [<a href="#rid12">12</a>]. Pooled data indicated a statistical but not clinically meaningful improvement in maximum inspiratory pressures (11 cmH<sub>2</sub>0, 95% CI 7.4-15.5). These analyses suggest that IMT may not improve dyspnea, functional exercise capacity, and quality of life when used with PR. However, IMT is likely to improve these outcomes when provided alone.</p><p>A separate systematic review indicated that expiratory muscle training improves expiratory muscle forces, but not the six minute walk distance or dyspnea in patients with COPD [<a href="#rid13">13</a>]. More data are needed to clarify the possible role of expiratory muscle training on clinical outcomes.</p><p class="headingAnchor" id="H3"><span class="h2">Strength training</span><span class="headingEndMark"> — </span>Training for strength is achieved by a high intensity, short duration stimulus, such as performance of inspiratory maneuvers against a closed glottis or shutter. An increase in maximal inspiratory pressures has been demonstrated when the respiratory muscles have been specifically trained for strength [<a href="#rid14">14,15</a>]. Respiratory muscle strength has also been shown to increase as a by-product of endurance training. It is therefore possible that some of the observed benefits reported after endurance training may be related to the associated increase in strength.</p><p class="headingAnchor" id="H4"><span class="h2">Endurance training</span><span class="headingEndMark"> — </span>Training for endurance is achieved by low intensity, high repetition training. Three types of programs have been used: flow resistive loading; threshold loading; and voluntary isocapnic hyperpnea.</p><p class="headingAnchor" id="H5"><span class="h3">Flow resistive loading</span><span class="headingEndMark"> — </span>Data from numerous studies indicate that ventilatory muscle training with flow resistive breathing results in improved ventilatory muscle strength and endurance, but has marginal effects on overall exercise performance [<a href="#rid7">7</a>]. It is not clear whether improved strength and endurance will result in decreased morbidity or mortality or offers other clinical advantages.</p><p>In flow resistive load training, the load consists of using a device with an adjustable inspiratory breath hole size. The load will increase provided that frequency, tidal volume, and inspiratory time are held constant. Although most studies in patients with COPD have shown an improvement in the time that a given respiratory load can be maintained (ventilatory muscle endurance), the results have to be interpreted with caution, since endurance can be increased with changes in the pattern of breathing.</p><p>A number of controlled studies of resistive breathing have shown an increase in the endurance time that the ventilatory muscles could tolerate a known load [<a href="#rid15">15-23</a>]. Some have also shown a significant increase in strength [<a href="#rid15">15-17,19-22</a>] and exercise tolerance [<a href="#rid22">22</a>], and a decrease in dyspnea during inspiratory loading [<a href="#rid16">16,22</a>]. The pressure required to achieve training must exceed 30 percent of maximal inspiratory pressure [<a href="#rid15">15,22</a>]. In the studies which evaluated systemic exercise performance, there was a minimal increase in walking distance [<a href="#rid15">15,19,21-23</a>].</p><p class="headingAnchor" id="H6"><span class="h3">Threshold loading</span><span class="headingEndMark"> — </span>With threshold loading, the patient breathes through a device that requires the patient to generate a threshold or target level of work before inspiratory airflow can begin. The threshold pressure needed to initiate inspiratory flow is high enough to ensure training, independent of inspiratory flow rate. When threshold devices are used, the breathing pattern (inspiratory time and respiratory rate) is not as critically important because the pressure required to activate the threshold is independent of the flow.</p><p>The benefit of inspiratory threshold loading was demonstrated in a trial of 33 patients with severe COPD who were randomly assigned to receive high intensity training (highest tolerable inspiratory threshold load) or sham training (only 10 percent of the maximal inspiratory pressure) three times per week for eight weeks [<a href="#rid8">8</a>]. High intensity training resulted in a greater increase of the maximum inspiratory pressure (18 versus 5 cm H<sub>2</sub>O), maximum threshold pressure (21 versus 2 cm H<sub>2</sub>O), and six-minute walking distance (27 versus 5 meters), as well as improved dyspnea and fatigue, compared to sham training.</p><p>The utility of IMT in facilitating liberation from mechanical ventilation has been explored in several studies that included but were not limited to patients with COPD:</p><p class="bulletIndent1"><span class="glyph">●</span>In a randomized trial, 92 patients on mechanical ventilation were assigned to inspiratory muscle training (40 percent of maximal pressure 5 sets of 10 breaths twice a day, seven days a week) or usual care until extubation, tracheostomy, or death [<a href="#rid24">24</a>]. Muscle training improved inspiratory muscle strength and tidal volume compared with usual care but had no effect on weaning outcome. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>IMT with a threshold inspiratory device, starting at the highest tolerated pressure and titrating upwards, has been tested in patients unable to wean from prolonged mechanical ventilation. A single-center randomized trial enrolled 69 patients unable to wean from MV; 35 to the IMT and 34 to the sham group [<a href="#rid25">25</a>]. IMT was performed with a threshold inspiratory device, set at the highest pressure tolerated and progressed daily. Subjects completed four sets of 6 to 10 training breaths, five days per week. The weaning criterion was 72 consecutive hours without MV support. The IMT and sham groups respectively received 42 ± 26 versus 47 ± 33.0 days of mechanical ventilatory support prior to starting intervention. The sham group's pre- to post-training maximal inspiratory pressure (MIP) change was not significant, while the IMT group's MIP increased (-44 ± 18 versus -54 ± 18 cm H<sub>2</sub>O). Twenty-five of 35 IMT subjects weaned (71 percent, 95% CI 55 to 84 percent), while 16 of 34 (47 percent, 95% CI 31-63 percent) sham subjects weaned. The number of patients needed to be treated for effect was 4 (95% CI 2 to 80). </p><p></p><p class="bulletIndent1">An IMT program can lead to increased MIP and improved weaning outcome in failure-to-wean patients compared with sham treatment. These results are further supported by a randomized trial of 101 patients of whom 48 were assigned to the IMT group and 53 to the control group [<a href="#rid26">26</a>]. IMT was associated with a substantially higher gain in muscle strength as assessed by the maximal inspiratory pressure (-71 cm H<sub>2</sub>O [-51 to -83 cm H<sub>2</sub>O] versus -48 cm H<sub>2</sub>O [-36 to -72 cm H<sub>2</sub>O]). Outcomes at the 60th day of ICU were significantly better in the intervention group regarding both survival (71 versus 49 percent) and weaning success (75 versus 45 percent). These studies support a potential use of IMT in patients with weak respiratory muscles unable to wean after prolonged MV.</p><p></p><p>For patients who have already weaned from mechanical ventilation, a course of IMT may improve exercise capacity. In a small study, 29 patients with COPD who remained hypercapnic after successful weaning from mechanical ventilation to noninvasive ventilation were randomized to IMT or sham training for four weeks during a pulmonary rehabilitation program [<a href="#rid9">9</a>]. Patients in the IMT group significantly improved their walking distance (3 to 186 m) and their maximal inspiratory pressure (-6 to -33 cm H<sub>2</sub>O), suggesting that IMT significantly enhances functional exercise capacity and increases respiratory muscle strength and power. However, no major changes were seen in arterial blood gases and no evidence was presented for effect on health status.</p><p class="headingAnchor" id="H7"><span class="h3">Voluntary isocapnic hyperpnea</span><span class="headingEndMark"> — </span>Voluntary isocapnic hyperpnea is a training method in which patients maintain high levels of ventilation over time (for 15 minutes, two or three times daily). Sufficient carbon dioxide is added to inspired gas to maintain a constant arterial tension of carbon dioxide (PaCO<sub>2</sub>), which is measured indirectly by the end-tidal partial pressure of CO<sub>2</sub> (EtCO<sub>2</sub>). (See  <a class="medical medical_review" href="/d/html/273.html" rel="external">"Carbon dioxide monitoring (capnography)"</a>.)</p><p>Studies evaluating the efficacy of respiratory muscle endurance training using voluntary isocapnic hyperpnea have had different results. Two controlled studies reported increases of maximal sustained ventilatory capacity (MSVC) in patients with COPD who were trained for six weeks, but the improvement in exercise endurance was no better than that observed in the control group [<a href="#rid27">27,28</a>]. In contrast, a subsequent study demonstrated improvement of endurance exercise capacity, respiratory muscle endurance capacity, perception of dyspnea, and quality of life compared to control subjects [<a href="#rid29">29</a>].</p><p>In a variation of hyperpnea training, 313 patients who underwent open cardiac surgery were randomly assigned to daily home training with deep breathing exercises for two months or to usual care. No differences were observed in health status measured with the short form 36 questionnaire or in lung function [<a href="#rid30">30</a>].</p><p class="headingAnchor" id="H516278452"><span class="h2">Novel training methods</span><span class="headingEndMark"> — </span>The use of non-conventional methods of training to improve ventilator muscle synchronization and function has gained some attention. Amongst them, the implementation of Tai-Chi techniques for patients with COPD was the topic of a Cochrane Database Systematic review of 12 randomized trials with 984 patients, lasting from six weeks up to one year. In total, the review documented a small but significant improvement in the six-minute walk distance (mean difference [MD] 29.6 meters, 95% CI 10.5-48.8 meters) and in the FEV<sub>1</sub> (0.11 L, 95% CI 0.02-0.20 L). However, the effect on dyspnea and health status remained inconclusive. More studies are needed to establish the value of these training methods on health resource utilization and outcomes.</p><p class="headingAnchor" id="H5625014"><span class="h2">Potential deleterious effects</span><span class="headingEndMark"> — </span>There is also the potential for ventilatory muscle training to be deleterious. Breathing at a high proportion of the functional reserve or with a prolonged inspiratory time may induce muscle fatigue [<a href="#rid31">31</a>]. Both factors are an intrinsic part of training; it is therefore possible that a sufficiently intense training program may precipitate fatigue. This may explain why compliance with such training programs is low, with up to 50 percent of patients failing to complete the studies.</p><p class="headingAnchor" id="H9"><span class="h1">RESPIRATORY MUSCLE RESTING</span><span class="headingEndMark"> — </span>Respiratory muscles may fatigue when working against a sufficiently large load. This has been shown to occur experimentally in normal volunteers and patients with chronic obstructive pulmonary disease (COPD) [<a href="#rid1">1-3</a>]. Clinically, respiratory muscle fatigue appears to play an important role in the acute respiratory failure of patients with COPD. In comparison, patients with chronic stable COPD are not suffering from chronic respiratory muscle fatigue.</p><p class="headingAnchor" id="H10"><span class="h2">Acute on chronic respiratory failure</span><span class="headingEndMark"> — </span>For patients with acute on chronic respiratory failure due to an exacerbation of COPD, the use of noninvasive ventilation (NIV), which enables respiratory muscle unloading and resting, has been shown to be beneficial [<a href="#rid32">32-35</a>]. The implementation of NIV for acute on chronic respiratory failure in COPD is discussed separately. (See  <a class="medical medical_review" href="/d/html/1636.html" rel="external">"Noninvasive ventilation in adults with acute respiratory failure: Benefits and contraindications"</a>.)</p><p>Patients best suited for this method were those with elevated arterial PCO<sub>2</sub> who were able to cooperate with the care givers and had no other important co-morbid problems, such as sepsis or severe pneumonia. Because NIV is potentially dangerous, patients considered for this therapy should be closely monitored and treated by individuals familiar with this ventilatory technique [<a href="#rid36">36</a>].</p><p>The various trials evaluated different outcomes, including rate of intubation, length of stay in the intensive care unit or in the hospital, dyspnea, and mortality. Although not all studies found the same results in the most important outcomes (such as mortality, intubation, length of hospital stay, and complications such as pneumonia), there was uniform agreement that respiratory muscle resting using NIV was effective in reversing acute respiratory failure and preventing complications. Approximately, five patients need to be treated with acute NIV to prevent one intubation and only eight patients need to be treated to prevent one death [<a href="#rid37">37</a>]. </p><p class="headingAnchor" id="H11"><span class="h2">Chronic stable COPD</span><span class="headingEndMark"> — </span>The possibility that the respiratory muscles of patients with severe COPD are functioning close to the threshold for fatigue, as suggested by chronic hypoventilation and consequent hypercapnia, has led numerous investigators to explore a potential role of resting the respiratory muscles with noninvasive negative or positive pressure ventilation. While older trials showed no benefit to NIV for most of the outcomes studied [<a href="#rid31">31,38-43</a>], subsequent trials that employed higher inspiratory pressures (so-called high-intensity NIV) with an aim to reduce arterial tension of carbon dioxide (PaCO<sub>2</sub>) to normal or near-normal levels have offered more favorable results [<a href="#rid44">44-46</a>]. </p><p>The European Respiratory Society (ERS) and the American Thoracic Society (ATS) independently reviewed the role of NIV in stable hypercapnic COPD using evidence-based systematic review methodology [<a href="#rid47">47,48</a>]. The ERS concluded that high-intensity NIV may decrease exacerbations, reduce dyspnea (as measured by improvements in the Medical Research Council Dyspnea score), and improve health-related quality of life, although they noted a low certainty of evidence [<a href="#rid47">47</a>]. Similarly, the ATS systematic review found that potential benefits of NIV included reductions in hospital admissions and dyspnea and also improved functional capacity and six-minute walk distance [<a href="#rid48">48</a>]. It seems possible that high-intensity NIV achieves these results through more successful rest of the diaphragm than was achieved in the earlier studies of lower intensity NIV [<a href="#rid47">47</a>].  </p><p>Based on these evidence-supported documents, an expert panel from several societies (ATS, American College of Chest Physicians, American Association of Respiratory Care, and the American Academy of Sleep Medicine) published practical recommendations aimed at improving the application of NIV for patients with hypercapnic stable COPD (PaCO<sub>2</sub> ≥52 mmHg on the patient’s usual oxygen supplementation regimen) [<a href="#rid49">49</a>]. For such patients, the panel advises the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Obstructive sleep apnea (OSA) should be considered and excluded on clinical grounds (no formal study needed). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bi-level positive airway pressure (BPAP) ventilation with a backup rate is preferred for initial therapy in most patients. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The patient should be seen between 31 to 90 days after initiation of NIV to monitor adherence and response to therapy. If the ventilation goals are achieved (patient is adherent with four hours or more of NIV per night and clinical improvement noted), NIV should be continued with frequent monitoring. If the patient fails to achieve these goals, transition to a home mechanical ventilator should be considered. </p><p></p><p>In spite of the great advances in the appropriate selection of COPD patients who may benefit from long term NIV, more studies are needed to better identify patients who are likely to benefit and to clarify the optimal NIV settings.</p><p>The use of nocturnal NIV in patients with severe COPD and hypercapnia is discussed in greater detail separately. (See  <a class="medical medical_review" href="/d/html/1453.html" rel="external">"Nocturnal ventilatory support in COPD"</a>.) </p><p class="headingAnchor" id="H1588277282"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/110267.html" rel="external">"Society guideline links: Chronic obstructive pulmonary disease"</a>.)</p><p class="headingAnchor" id="H12"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span>In patients with COPD, respiratory muscle training increases the strength and capacity of the muscles to endure a respiratory load. Inspiratory muscle training (IMT) is likely to improve dyspnea, functional exercise capacity, and quality of life when provided alone. However, IMT may not improve these outcomes when used as a component of a pulmonary rehabilitation program. (See <a class="local">'Strength and endurance training'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>It seems logical to predict that increases in strength and endurance would help respiratory muscle function. However, this may only be relevant when patients must handle inspiratory loads that are greater than baseline, such as during an acute exacerbation or exercise. (See <a class="local">'Strength and endurance training'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The exact criteria for patient selection remain unclear. Stable patients with dyspnea and respiratory muscle weakness are likely to benefit from respiratory muscle training. IMT may be beneficial in patients with respiratory muscle weakness who have been unable to wean after long-term mechanical ventilation, but further study is needed. (See <a class="local">'Strength and endurance training'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Respiratory muscle training can induce deleterious effects, such as an uncomfortable degree of fatigue, when breathing at a high proportion of the functional reserve or with a prolonged inspiratory time. (See <a class="local">'Potential deleterious effects'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For patients with an exacerbation of COPD complicated by hypercapnic acidosis (arterial tension of carbon dioxide [PaCO<sub>2</sub>] &gt;45 mmHg or pH &lt;7.30) who do not require emergent intubation and lack contraindications to NIV, a trial of bilevel noninvasive ventilation (NIV) is advised, as described in detail separately. (See <a class="local">'Respiratory muscle resting'</a> above and  <a class="medical medical_review" href="/d/html/1636.html" rel="external">"Noninvasive ventilation in adults with acute respiratory failure: Benefits and contraindications"</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Intermittent respiratory muscle rest during nocturnal NIV using sufficient inspiratory pressures to reduce PaCO<sub>2</sub> to normal or near-normal levels (so-called high-intensity NIV) may be of benefit in stable patients with severe hypercapnic COPD. NIV appears more effective in patients discharged after hospitalization for an exacerbation who remain hypercapnic (PaCO<sub>2</sub> &gt;55 mmHg) with a stable pH (&gt;7.30), although more study is needed to clarify the risks and benefits. (See <a class="local">'Chronic stable COPD'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Roussos C, Macklem PT. The respiratory muscles. N Engl J Med 1982; 307:786.</a></li><li><a class="nounderline abstract_t">Rochester DF. The diaphragm: contractile properties and fatigue. J Clin Invest 1985; 75:1397.</a></li><li><a class="nounderline abstract_t">Celli BR. Respiratory muscle function. Clin Chest Med 1986; 7:567.</a></li><li><a class="nounderline abstract_t">Levine S, Kaiser L, Leferovich J, Tikunov B. Cellular adaptations in the diaphragm in chronic obstructive pulmonary disease. N Engl J Med 1997; 337:1799.</a></li><li><a class="nounderline abstract_t">Testelmans D, Crul T, Maes K, et al. Atrophy and hypertrophy signalling in the diaphragm of patients with COPD. Eur Respir J 2010; 35:549.</a></li><li><a class="nounderline abstract_t">Leith DE, Bradley M. Ventilatory muscle strength and endurance training. J Appl Physiol 1976; 41:508.</a></li><li><a class="nounderline abstract_t">Gosselink R, De Vos J, van den Heuvel SP, et al. Impact of inspiratory muscle training in patients with COPD: what is the evidence? Eur Respir J 2011; 37:416.</a></li><li><a class="nounderline abstract_t">Hill K, Jenkins SC, Philippe DL, et al. High-intensity inspiratory muscle training in COPD. Eur Respir J 2006; 27:1119.</a></li><li><a class="nounderline abstract_t">Dellweg D, Reissig K, Hoehn E, et al. Inspiratory muscle training during rehabilitation in successfully weaned hypercapnic patients with COPD. Respir Med 2017; 123:116.</a></li><li><a class="nounderline abstract_t">Beaumont M, Forget P, Couturaud F, Reychler G. Effects of inspiratory muscle training in COPD patients: A systematic review and meta-analysis. Clin Respir J 2018; 12:2178.</a></li><li><a class="nounderline abstract_t">Weiner P, Magadle R, Beckerman M, et al. Comparison of specific expiratory, inspiratory, and combined muscle training programs in COPD. Chest 2003; 124:1357.</a></li><li><a class="nounderline abstract_t">Ammous O, Feki W, Lotfi T, et al. Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstructive pulmonary disease (COPD). Cochrane Database Syst Rev 2023; 1:CD013778.</a></li><li><a class="nounderline abstract_t">Neves LF, Reis MH, Plentz RD, et al. Expiratory and expiratory plus inspiratory muscle training improves respiratory muscle strength in subjects with COPD: systematic review. Respir Care 2014; 59:1381.</a></li><li><a class="nounderline abstract_t">Reid, WD, Warren, CP. Ventilatory muscle strength and endurance training in elderly subjects and patients with chronic airflow limitation: a pilot study. Physiol Canada 1984; 36:305.</a></li><li><a class="nounderline abstract_t">Larson JL, Kim MJ, Sharp JT, Larson DA. Inspiratory muscle training with a pressure threshold breathing device in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1988; 138:689.</a></li><li><a class="nounderline abstract_t">Harver A, Mahler DA, Daubenspeck JA. Targeted inspiratory muscle training improves respiratory muscle function and reduces dyspnea in patients with chronic obstructive pulmonary disease. Ann Intern Med 1989; 111:117.</a></li><li><a class="nounderline abstract_t">Belman MJ, Shadmehr R. Targeted resistive ventilatory muscle training in chronic obstructive pulmonary disease. J Appl Physiol (1985) 1988; 65:2726.</a></li><li><a class="nounderline abstract_t">Noseda A, Carpiaux JP, Vandeput W, et al. Resistive inspiratory muscle training and exercise performance in COPD patients. A comparative study with conventional breathing retraining. Bull Eur Physiopathol Respir 1987; 23:457.</a></li><li><a class="nounderline abstract_t">Weiner P, Azgad Y, Ganam R. Inspiratory muscle training combined with general exercise reconditioning in patients with COPD. Chest 1992; 102:1351.</a></li><li><a class="nounderline abstract_t">Belman MJ, Mittman C. Ventilatory muscle training improves exercise capacity in chronic obstructive pulmonary disease patients. Am Rev Respir Dis 1980; 121:273.</a></li><li><a class="nounderline abstract_t">Wanke T, Formanek D, Lahrmann H, et al. Effects of combined inspiratory muscle and cycle ergometer training on exercise performance in patients with COPD. Eur Respir J 1994; 7:2205.</a></li><li><a class="nounderline abstract_t">Lisboa C, Muñoz V, Beroiza T, et al. Inspiratory muscle training in chronic airflow limitation: comparison of two different training loads with a threshold device. Eur Respir J 1994; 7:1266.</a></li><li><a class="nounderline abstract_t">Ramirez-Sarmiento A, Orozco-Levi M, Guell R, et al. Inspiratory muscle training in patients with chronic obstructive pulmonary disease: structural adaptation and physiologic outcomes. Am J Respir Crit Care Med 2002; 166:1491.</a></li><li><a class="nounderline abstract_t">Condessa RL, Brauner JS, Saul AL, et al. Inspiratory muscle training did not accelerate weaning from mechanical ventilation but did improve tidal volume and maximal respiratory pressures: a randomised trial. J Physiother 2013; 59:101.</a></li><li><a class="nounderline abstract_t">Martin AD, Smith BK, Davenport PD, et al. Inspiratory muscle strength training improves weaning outcome in failure to wean patients: a randomized trial. Crit Care 2011; 15:R84.</a></li><li><a class="nounderline abstract_t">da Silva Guimarães B, de Souza LC, Cordeiro HF, et al. Inspiratory Muscle Training With an Electronic Resistive Loading Device Improves Prolonged Weaning Outcomes in a Randomized Controlled Trial. Crit Care Med 2021; 49:589.</a></li><li><a class="nounderline abstract_t">Ries AL, Moser KM. Comparison of isocapnic hyperventilation and walking exercise training at home in pulmonary rehabilitation. Chest 1986; 90:285.</a></li><li><a class="nounderline abstract_t">Levine S, Weiser P, Gillen J. Evaluation of a ventilatory muscle endurance training program in the rehabilitation of patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 133:400.</a></li><li><a class="nounderline abstract_t">Koppers RJ, Vos PJ, Boot CR, Folgering HT. Exercise performance improves in patients with COPD due to respiratory muscle endurance training. Chest 2006; 129:886.</a></li><li><a class="nounderline abstract_t">Westerdahl E, Urell C, Jonsson M, et al. Deep breathing exercises performed 2 months following cardiac surgery: a randomized controlled trial. J Cardiopulm Rehabil Prev 2014; 34:34.</a></li><li><a class="nounderline abstract_t">Celli B, Lee H, Criner G, et al. Controlled trial of external negative pressure ventilation in patients with severe chronic airflow obstruction. Am Rev Respir Dis 1989; 140:1251.</a></li><li><a class="nounderline abstract_t">Brochard L, Isabey D, Piquet J, et al. Reversal of acute exacerbations of chronic obstructive lung disease by inspiratory assistance with a face mask. N Engl J Med 1990; 323:1523.</a></li><li><a class="nounderline abstract_t">Kramer N, Meyer TJ, Meharg J, et al. Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure. Am J Respir Crit Care Med 1995; 151:1799.</a></li><li><a class="nounderline abstract_t">Bott J, Carroll MP, Conway JH, et al. Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease. Lancet 1993; 341:1555.</a></li><li><a class="nounderline abstract_t">Brochard L, Wysocki M, Lofaso F, et al. Face. Face mask inspiratory positive airway pressure (IPAP) for acute exacerbation of chronic respiratory insufficiency . A randomized study. Am Rev Respir Dis 1993; 147:984.</a></li><li><a class="nounderline abstract_t">Hill NS. Noninvasive ventilation for chronic obstructive pulmonary disease. Respir Care 2004; 49:72.</a></li><li><a class="nounderline abstract_t">Brochard L, Mancebo J, Wysocki M, et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1995; 333:817.</a></li><li><a class="nounderline abstract_t">Zibrak JD, Hill NS, Federman EC, et al. Evaluation of intermittent long-term negative-pressure ventilation in patients with severe chronic obstructive pulmonary disease. Am Rev Respir Dis 1988; 138:1515.</a></li><li><a class="nounderline abstract_t">Shapiro SH, Ernst P, Gray-Donald K, et al. Effect of negative pressure ventilation in severe chronic obstructive pulmonary disease. Lancet 1992; 340:1425.</a></li><li><a class="nounderline abstract_t">Strumpf DA, Millman RP, Carlisle CC, et al. Nocturnal positive-pressure ventilation via nasal mask in patients with severe chronic obstructive pulmonary disease. Am Rev Respir Dis 1991; 144:1234.</a></li><li><a class="nounderline abstract_t">Casanova C, Celli BR, Tost L, et al. Long-term controlled trial of nocturnal nasal positive pressure ventilation in patients with severe COPD. Chest 2000; 118:1582.</a></li><li><a class="nounderline abstract_t">Clini E, Sturani C, Rossi A, et al. The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients. Eur Respir J 2002; 20:529.</a></li><li><a class="nounderline abstract_t">COPD Working Group. Noninvasive positive pressure ventilation for chronic respiratory failure patients with stable chronic obstructive pulmonary disease (COPD): an evidence-based analysis. Ont Health Technol Assess Ser 2012; 12:1.</a></li><li><a class="nounderline abstract_t">Struik FM, Sprooten RT, Kerstjens HA, et al. Nocturnal non-invasive ventilation in COPD patients with prolonged hypercapnia after ventilatory support for acute respiratory failure: a randomised, controlled, parallel-group study. Thorax 2014; 69:826.</a></li><li><a class="nounderline abstract_t">Köhnlein T, Windisch W, Köhler D, et al. Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial. Lancet Respir Med 2014; 2:698.</a></li><li><a class="nounderline abstract_t">Murphy PB, Rehal S, Arbane G, et al. Effect of Home Noninvasive Ventilation With Oxygen Therapy vs Oxygen Therapy Alone on Hospital Readmission or Death After an Acute COPD Exacerbation: A Randomized Clinical Trial. JAMA 2017; 317:2177.</a></li><li><a class="nounderline abstract_t">Ergan B, Oczkowski S, Rochwerg B, et al. European Respiratory Society guidelines on long-term home non-invasive ventilation for management of COPD. Eur Respir J 2019; 54.</a></li><li><a class="nounderline abstract_t">Macrea M, Oczkowski S, Rochwerg B, et al. Long-Term Noninvasive Ventilation in Chronic Stable Hypercapnic Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med 2020; 202:e74.</a></li><li><a class="nounderline abstract_t">Hill NS, Criner GJ, Branson RD, et al. Optimal NIV Medicare Access Promotion: Patients With COPD: A Technical Expert Panel Report From the American College of Chest Physicians, the American Association for Respiratory Care, the American Academy of Sleep Medicine, and the American Thoracic Society. Chest 2021; 160:e389.</a></li></ol></div><div id="topicVersionRevision">Topic 1452 Version 21.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7050712" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : The respiratory muscles.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3889054" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : The diaphragm: contractile properties and fatigue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3539472" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Respiratory muscle function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9400036" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Cellular adaptations in the diaphragm in chronic obstructive pulmonary disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19717478" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Atrophy and hypertrophy signalling in the diaphragm of patients with COPD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/985393" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Ventilatory muscle strength and endurance training.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21282809" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Impact of inspiratory muscle training in patients with COPD: what is the evidence?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16772388" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : High-intensity inspiratory muscle training in COPD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28137487" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Inspiratory muscle training during rehabilitation in successfully weaned hypercapnic patients with COPD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29665262" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Effects of inspiratory muscle training in COPD patients: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14555566" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Comparison of specific expiratory, inspiratory, and combined muscle training programs in COPD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36606682" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstructive pulmonary disease (COPD).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24782553" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Expiratory and expiratory plus inspiratory muscle training improves respiratory muscle strength in subjects with COPD: systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Ventilatory muscle strength and endurance training in elderly subjects and patients with chronic airflow limitation: a pilot study</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3202422" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Inspiratory muscle training with a pressure threshold breathing device in patients with chronic obstructive pulmonary disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2742247" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Targeted inspiratory muscle training improves respiratory muscle function and reduces dyspnea in patients with chronic obstructive pulmonary disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3215873" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Targeted resistive ventilatory muscle training in chronic obstructive pulmonary disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3450328" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Resistive inspiratory muscle training and exercise performance in COPD patients. A comparative study with conventional breathing retraining.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1424850" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Inspiratory muscle training combined with general exercise reconditioning in patients with COPD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7362134" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Ventilatory muscle training improves exercise capacity in chronic obstructive pulmonary disease patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7713205" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Effects of combined inspiratory muscle and cycle ergometer training on exercise performance in patients with COPD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7925905" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Inspiratory muscle training in chronic airflow limitation: comparison of two different training loads with a threshold device.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12406842" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Inspiratory muscle training in patients with chronic obstructive pulmonary disease: structural adaptation and physiologic outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23663795" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Inspiratory muscle training did not accelerate weaning from mechanical ventilation but did improve tidal volume and maximal respiratory pressures: a randomised trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21385346" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Inspiratory muscle strength training improves weaning outcome in failure to wean patients: a randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33332819" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Inspiratory Muscle Training With an Electronic Resistive Loading Device Improves Prolonged Weaning Outcomes in a Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3731904" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Comparison of isocapnic hyperventilation and walking exercise training at home in pulmonary rehabilitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3954249" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Evaluation of a ventilatory muscle endurance training program in the rehabilitation of patients with chronic obstructive pulmonary disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16608934" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Exercise performance improves in patients with COPD due to respiratory muscle endurance training.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24280904" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Deep breathing exercises performed 2 months following cardiac surgery: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2683904" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Controlled trial of external negative pressure ventilation in patients with severe chronic airflow obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2122253" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Reversal of acute exacerbations of chronic obstructive lung disease by inspiratory assistance with a face mask.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7767523" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8099639" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Face mask inspiratory positive airway pressure (IPAP) for acute exacerbation of chronic respiratory insufficiency . A randomized study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14733624" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Noninvasive ventilation for chronic obstructive pulmonary disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7651472" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3059898" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Evaluation of intermittent long-term negative-pressure ventilation in patients with severe chronic obstructive pulmonary disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1360558" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Effect of negative pressure ventilation in severe chronic obstructive pulmonary disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1741532" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Nocturnal positive-pressure ventilation via nasal mask in patients with severe chronic obstructive pulmonary disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11115443" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Long-term controlled trial of nocturnal nasal positive pressure ventilation in patients with severe COPD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12358325" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23074437" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Noninvasive positive pressure ventilation for chronic respiratory failure patients with stable chronic obstructive pulmonary disease (COPD): an evidence-based analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24781217" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Nocturnal non-invasive ventilation in COPD patients with prolonged hypercapnia after ventilatory support for acute respiratory failure: a randomised, controlled, parallel-group study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25066329" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28528348" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Effect of Home Noninvasive Ventilation With Oxygen Therapy vs Oxygen Therapy Alone on Hospital Readmission or Death After an Acute COPD Exacerbation: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31467119" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : European Respiratory Society guidelines on long-term home non-invasive ventilation for management of COPD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32795139" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Long-Term Noninvasive Ventilation in Chronic Stable Hypercapnic Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34339684" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Optimal NIV Medicare Access Promotion: Patients With COPD: A Technical Expert Panel Report From the American College of Chest Physicians, the American Association for Respiratory Care, the American Academy of Sleep Medicine, and the American Thoracic Society.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
